Selective alpha 2B/2C agonists
US8329918B2 · kind B2 · utility
7Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2010 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Dec 17, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D263/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds useful as agonists of alpha 2B/2C receptors. Pharmaceutical compositions including the presently described compounds and methods of treatment of diseases and conditions with the presently described compounds also are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.